about
A natural-like synthetic small molecule impairs bcr-abl signaling cascades and induces megakaryocyte differentiation in erythroleukemia cellsGlucokinase regulatory protein gene polymorphism affects liver fibrosis in non-alcoholic fatty liver diseaseAntiproliferative agents that interfere with the cell cycle at the G1-->S transition: further development and characterization of a small library of stilbene-derived compounds.Substituted 2-(3',4',5'-trimethoxybenzoyl)-benzo[b]thiophene derivatives as potent tubulin polymerization inhibitors.PNPLA3 GG genotype and carotid atherosclerosis in patients with non-alcoholic fatty liver disease.Synthesis of novel antimitotic agents based on 2-amino-3-aroyl-5-(hetero)arylethynyl thiophene derivativesSynthesis, antiproliferative activity, and mechanism of action of a series of 2-{[(2E)-3-phenylprop-2-enoyl]amino}benzamidesSynthesis and biological evaluation of 2-(3',4',5'-trimethoxybenzoyl)-3-N,N-dimethylamino benzo[b]furan derivatives as inhibitors of tubulin polymerization.Design, synthesis and structure-activity relationship of 2-(3',4',5'-trimethoxybenzoyl)-benzo[b]furan derivatives as a novel class of inhibitors of tubulin polymerization.Inhibition of activated STAT5 in Bcr/Abl expressing leukemia cells with new pimozide derivatives.Insulin-like growth factor-I, inflammatory proteins, and fibrosis in subjects with nonalcoholic fatty liver disease.Synthesis of substituted 3-amino-N-phenyl-1H-indazole-1-carboxamides endowed with antiproliferative activity.Novel terphenyls and 3,5-diaryl isoxazole derivatives endowed with growth supporting and antiapoptotic properties.Synthesis and antiproliferative activity of 3-amino-N-phenyl-1H-indazole-1-carboxamides.Galangin increases the cytotoxic activity of imatinib mesylate in imatinib-sensitive and imatinib-resistant Bcr-Abl expressing leukemia cells.TM6SF2 rs58542926 is not associated with steatosis and fibrosis in large cohort of patients with genotype 1 chronic hepatitis C.Novel antiproliferative chimeric compounds with marked histone deacetylase inhibitory activity.PNPLA3 rs738409 I748M is associated with steatohepatitis in 434 non-obese subjects with hepatitis C.Role of IL-28B and inosine triphosphatase polymorphisms in efficacy and safety of Peg-Interferon and ribavirin in chronic hepatitis C compensated cirrhosis with and without oesophageal varices.Association of vitamin D serum levels and its common genetic determinants, with severity of liver fibrosis in genotype 1 chronic hepatitis C patients.Identification of biphenyl-based hybrid molecules able to decrease the intracellular level of Bcl-2 protein in Bcl-2 overexpressing leukemia cells.The UCP2 -866 G>A promoter region polymorphism is associated with nonalcoholic steatohepatitis.High liver RBP4 protein content is associated with histological features in patients with genotype 1 chronic hepatitis C and with nonalcoholic steatohepatitis.Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease.3-Aryl-2-[1H-benzotriazol-1-yl]acrylonitriles: a novel class of potent tubulin inhibitors.Statin use and non-alcoholic steatohepatitis in at risk individuals.Genetic predisposition to thrombophilia in inflammatory bowel disease.IL28B and PNPLA3 polymorphisms affect histological liver damage in patients with non-alcoholic fatty liver disease
P50
Q28486933-22AD78D2-9B10-45FC-9FB6-89DC2AED0522Q28539434-D7021CF2-BA8E-4A04-B525-4A9D0EC1C87AQ33312483-E103429D-7F68-4515-BCA6-E0427E2D9FD5Q34070809-E3655D24-553E-47ED-830B-5B807B26757CQ34998991-F96F75C8-A048-4D1F-84F7-E5A9FD51C648Q35008501-4A0B8480-0D3A-43F4-9E83-4AFAC17725C5Q35060287-6F250D79-16A3-427D-8281-E65A6BA82C90Q36952871-68959DC8-6B8B-4C03-B24C-A4AEF0F805F8Q37388318-163CEFBB-540E-46D0-90D4-F0BC6AFD646FQ38965129-377F3376-4B80-49C6-A2FA-87E4237B63FBQ39211194-06BBC616-82E7-4EB9-85D3-9490E2A753D8Q39624044-88606543-D3FA-4C75-AF30-AD76D0805A4CQ39962353-4ECAFC99-396B-4818-BA03-96FC5B0FE0F2Q39981396-605E11FA-B0B6-474D-993C-81C920F73398Q39997299-B65951B8-5FB5-432A-9EA1-D3B48860593EQ41498105-3FFF5CCC-5CAB-479C-A777-6E9E4ABF3F63Q41739570-F48838DA-5510-4684-A50D-17899A14997CQ42153080-500D70C3-82C6-427A-A73E-570EBD8EFA13Q42988052-B0F86A9A-D684-4B7C-B777-9BE342DFB2ACQ42992752-B0A2206A-5948-4752-837A-3C2D24DC43AAQ43274608-9412F1D0-E1EF-4CA8-A4F6-D70A49C5261CQ46820686-98A34182-07B8-4F01-9CAD-3D4F8B563183Q50162879-6A6998CA-0EB6-449B-85A6-5FD8CF218AF5Q51315380-836B6E50-9489-4EB5-B8B2-54E90A362261Q53234544-FB049D56-3834-48B3-807A-AB29477BECE5Q53504568-9FDDBA2D-DCEE-45AE-BFA4-A91A7EB64D63Q53790913-59EDF739-E59E-4A92-8ACE-FAD0452C2BE2Q56119444-9C9432AC-2FD8-4F0C-A695-4A79864E09CC
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Rosaria Maria Pipitone
@ast
Rosaria Maria Pipitone
@en
Rosaria Maria Pipitone
@es
Rosaria Maria Pipitone
@nl
type
label
Rosaria Maria Pipitone
@ast
Rosaria Maria Pipitone
@en
Rosaria Maria Pipitone
@es
Rosaria Maria Pipitone
@nl
prefLabel
Rosaria Maria Pipitone
@ast
Rosaria Maria Pipitone
@en
Rosaria Maria Pipitone
@es
Rosaria Maria Pipitone
@nl
P106
P1153
23983473600
P21
P31
P496
0000-0002-6721-3962